Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Bruyère, Olivier; Cooper, Cyrus; Al-Daghri, Nasser M.; Dennison, Elaine M.; Rizzoli, René; Reginster, Jean-Yves

doi:10.1007/s40520-017-0861-1

Scientific article

Review

English

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

ContributorsBruyère, Olivier; Cooper, Cyrus; Al-Daghri, Nasser M.; Dennison, Elaine M.; Rizzoli, René; Reginster, Jean-Yves

Published inAging Clinical and Experimental Research, vol. 30, no. 2, p. 111-117

Publication date2018

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Génétique des ostéoporoses (544)

Citation (ISO format)

BRUYÈRE, Olivier et al. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). In: Aging Clinical and Experimental Research, 2018, vol. 30, n° 2, p. 111–117. doi: 10.1007/s40520-017-0861-1